In Vivo: strategic insights for life sciences decision-maker...
Falling At The Start Line: Chinese Firms Face Multiple Commercial Challenges Beyond Price, Coverage
By Brian Yang 06 Jun 2023
Sales of a global first-in-class dermatology drug that gained its first approval in China are falling well behind those of...